Mirum Pharmaceuticals, Inc., headquartered in Foster City, California, is a biopharmaceutical company dedicated to developing innovative therapies for severe liver diseases. The company boasts a strong pipeline, featuring novel treatment candidates that target significant unmet medical needs in hepatology. With a clear focus on clinical development and a commitment to patient-centered care, Mirum presents a compelling opportunity for institutional investors seeking exposure to transformative growth in the evolving healthcare landscape.